Last reviewed · How we verify

NCT04119258

Therapist Adherence to Cognitive-behavioral Therapy

Completed Last updated 19 October 2023
What this trial tests

trial testing Cognitive-behavioral therapy in Depression in 106 participants. Completed in 30 June 2023.

Timeline
1 November 2019
Primary endpoint
30 June 2023
30 June 2023

Quick facts

Lead sponsorKarolinska Institutet
StatusCompleted
Study typeOBSERVATIONAL
Enrollment106
Start date1 November 2019
Primary completion30 June 2023
Estimated completion30 June 2023
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Depression or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational web-based survey on therapist adherence to evidence-based cognitive-behavioral therapy (CBT) in the perspective of their patients with depression or anxiety disorders in psychiatric outpatient care in Stockholm, Sweden. Following completion of CBT, participants respond to questions including their age, gender, education, whether they have improved, whether they considered treatment helpful, and an instrument measuring therapist adherence to CBT procedures (e.g., setting agenda, follow up on home assignments) and CBT techniques (e.g., exposure, cognitive restructuring). The purpose of the study is to contribute to quality assurance of CBT in Stockholm Health Care Services.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive-behavioral therapy

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing